Needham Downgrades Covidien To Hold

Analysts at Needham downgraded Covidien plc COV from Buy to Hold and removed the price target of $80. Covidien shares have jumped 47.09% over the past 52 weeks, while the S&P 500 index has surged 17.89% in the same period. Covidien's shares fell 1.73% to close at $88.93 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsNeedham
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!